Henrik Birn

8.3k total citations · 1 hit paper
164 papers, 5.9k citations indexed

About

Henrik Birn is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Henrik Birn has authored 164 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Nephrology, 38 papers in Molecular Biology and 30 papers in Surgery. Recurrent topics in Henrik Birn's work include Renal Diseases and Glomerulopathies (31 papers), Chronic Kidney Disease and Diabetes (29 papers) and Folate and B Vitamins Research (16 papers). Henrik Birn is often cited by papers focused on Renal Diseases and Glomerulopathies (31 papers), Chronic Kidney Disease and Diabetes (29 papers) and Folate and B Vitamins Research (16 papers). Henrik Birn collaborates with scholars based in Denmark, United Kingdom and Sweden. Henrik Birn's co-authors include Erik Christensen, Rikke Nielsen, P Verroust, Søren K. Moestrup, Ebba Nexø, Kathrin Weyer, Christian Jacobsen, H. P. Philipsen, Erik Christensen and Tina Storm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Henrik Birn

157 papers receiving 5.7k citations

Hit Papers

Megalin and cubilin: mult... 2002 2026 2010 2018 2002 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Henrik Birn 2.2k 1.5k 785 769 713 164 5.9k
Motoko Yanagita 2.8k 1.3× 2.0k 1.4× 1.2k 1.5× 511 0.7× 483 0.7× 250 7.6k
Serge Cremers 1.7k 0.8× 947 0.6× 808 1.0× 885 1.2× 401 0.6× 144 6.5k
Martine Cohen‐Solal 2.4k 1.1× 813 0.5× 862 1.1× 403 0.5× 1.4k 2.0× 242 6.1k
Gerhard A. Müller 3.5k 1.6× 2.9k 1.9× 1.3k 1.7× 739 1.0× 1.0k 1.4× 302 10.5k
Frederick R. Singer 2.8k 1.3× 1.5k 1.0× 874 1.1× 1.2k 1.6× 1.7k 2.3× 189 10.3k
Masayuki Iwano 3.4k 1.5× 2.6k 1.8× 1.1k 1.5× 669 0.9× 700 1.0× 138 8.4k
Eduardo Salido 3.8k 1.7× 603 0.4× 710 0.9× 928 1.2× 489 0.7× 222 7.2k
Neal S. Fedarko 3.4k 1.5× 925 0.6× 544 0.7× 373 0.5× 2.3k 3.3× 108 8.2k
Hirokazu Okada 3.4k 1.5× 2.8k 1.9× 1.3k 1.7× 536 0.7× 319 0.4× 220 8.9k
Karl Insogna 5.9k 2.7× 3.1k 2.1× 1.4k 1.8× 1.4k 1.8× 1.1k 1.6× 237 15.1k

Countries citing papers authored by Henrik Birn

Since Specialization
Citations

This map shows the geographic impact of Henrik Birn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Birn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Birn more than expected).

Fields of papers citing papers by Henrik Birn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Birn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Birn. The network helps show where Henrik Birn may publish in the future.

Co-authorship network of co-authors of Henrik Birn

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Birn. A scholar is included among the top collaborators of Henrik Birn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Birn. Henrik Birn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Simon Kok, Michael Lejbach Bertelsen, Mette Nørgaard, et al.. (2025). Occurrence and prognosis of chronic kidney disease in Denmark – a nationwide population-based cohort study. Clinical Kidney Journal. 18(6). sfaf147–sfaf147.
2.
Faivre, Anna, et al.. (2025). In vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis. Science Advances. 11(43). eadz5358–eadz5358.
3.
Birn, Henrik, et al.. (2024). The Cyst Epithelium in Polycystic Kidney Disease Patients Displays Normal Apical-Basolateral Cell Polarity. Physiology. 39(S1). 1 indexed citations
4.
Andersen, Henrik Ørbæk, Kathrin Weyer, Jan Erik Henriksen, et al.. (2024). Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria. Journal of the American Society of Nephrology. 35(4). 410–425. 4 indexed citations
5.
Jensen, Simon Kok, Uffe Heide‐Jørgensen, Line Elmerdahl Frederiksen, et al.. (2024). Risk factor analysis for a rapid progression of chronic kidney disease. Nephrology Dialysis Transplantation. 39(7). 1150–1158. 11 indexed citations
6.
Khatir, Dinah Sherzad, Henrik Birn, Niels Henrik Buus, et al.. (2024). A Urine pH-Ammonium Acid/Base Score and CKD Progression. Journal of the American Society of Nephrology. 35(11). 1533–1545. 3 indexed citations
7.
Pedersen, Katja Venborg, Mads Malik Aagaard, Jesper Graakjær, et al.. (2024). The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years. Clinical Kidney Journal. 17(7). sfae166–sfae166.
8.
Gustafsen, Camilla, Ditte Olsen, Per Ivarsen, et al.. (2023). Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome. Kidney International. 104(4). 754–768. 20 indexed citations
10.
Nørgaard, Mette, et al.. (2023). Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study. International Journal of Cancer. 154(7). 1164–1173. 2 indexed citations
11.
Genovese, Federica, Daniel Guldager Kring Rasmussen, M.A. Karsdal, et al.. (2023). Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients. Biomolecules. 13(5). 792–792. 5 indexed citations
12.
Birn, Henrik, et al.. (2023). Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial. Clinical Kidney Journal. 17(1). sfad249–sfad249. 29 indexed citations
13.
Birn, Henrik, et al.. (2023). Twenty-four-Year Trends in Incidence and Mortality of Nephrotic Syndrome: A Population-Based Cohort Study. Epidemiology. 34(3). 411–420. 6 indexed citations
14.
Heide‐Jørgensen, Uffe, Simon Kok Jensen, Henrik Birn, et al.. (2023). Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR. Clinical Kidney Journal. 16(12). 2728–2737. 3 indexed citations
15.
Oltean, Mihai, et al.. (2022). A comparison of four established GFR formulas to estimate measured GFR and changes in GFR in adult kidney transplant recipients. Scandinavian Journal of Clinical and Laboratory Investigation. 82(4). 296–303. 1 indexed citations
17.
Svenningsen, Per, Kirsten Madsen, Claus Bistrup, et al.. (2021). Proteinuria is accompanied by intratubular complement activation and apical membrane deposition of C3dg and C5b-9 in kidney transplant recipients. American Journal of Physiology-Renal Physiology. 322(2). F150–F163. 13 indexed citations
18.
Lildballe, Dorte L., et al.. (2021). Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants. European Journal of Medical Genetics. 64(4). 104183–104183. 4 indexed citations
19.
Christiansen, Christian Fynbo, et al.. (2021). Identification of Patients with CKD in Medical Databases. Clinical Journal of the American Society of Nephrology. 16(4). 543–551. 33 indexed citations
20.
Heide‐Jørgensen, Uffe, Heleen van Haalen, Glen James, et al.. (2020). <p>Risk of Anemia in Patients with Newly Identified Chronic Kidney Disease – A Population-Based Cohort Study</p>. Clinical Epidemiology. Volume 12. 953–962. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026